Dexrazoxane (ICRF-187)

This publication has 26 references indexed in Scilit:

• Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress.
  Proceedings of the National Academy of Sciences, 1996
• Ferrous Ion Strongly Promotes the Ring Opening of the Hydrolysis Intermediates of the Antioxidant Cardioprotective Agent Dexrazoxane (ICRF-187)
  Archives of Biochemistry and Biophysics, 1995
• An HPLC and spectrophotometric study of the hydrolysis of ICRF-187 (dexrazoxane, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane) and its one-ring opened intermediates
  International Journal of Pharmaceutics, 1994
• Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats
  Cancer Chemotherapy and Pharmacology, 1994
• Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.
  Heart, 1993
• The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925
  Inflammation Research, 1993
• Strategies for prevention of anthracycline cardiotoxicity
  Cancer Treatment Reviews, 1993
• Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
  New England Journal of Medicine, 1992
• The interaction of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin
  Inflammation Research, 1989
• Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites
  Journal of Clinical Investigation, 1980